Dexmedetomidine Reduces Sevoflurane EC50 for Supraglottic Airway Device Insertion in Spontaneously Breathing Morbidly Obese Patients
Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s199440
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2019
Authors
Publisher
Informa UK Limited